Common Dosing: Retatrutide is typically initiated at 2mg weekly, with likely boosts to 6mg or 8mg according to the patient’s response and demands. Administration Strategy Retatrutide is the newest weight loss medication that functions as being a triple agonist at GLP-one, GIP, and glucagon receptors. The medication is indicated for https://corepepptides.com/product/retatrutide-injection-pen/